|
TUBD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.550000E-01 |
| Stage1-vs-Stage3 |
6.723700E-02 |
| Stage1-vs-Stage4 |
1.304820E-03 |
| Stage2-vs-Stage3 |
8.408400E-01 |
| Stage2-vs-Stage4 |
9.858100E-02 |
| Stage3-vs-Stage4 |
9.766400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.69609889969047E-11 |
| Normal-vs-Asian |
2.79287704074704E-12 |
| Caucasian-vs-AfricanAmerican |
9.379200E-01 |
| Caucasian-vs-Asian |
4.641600E-02 |
| AfricanAmerican-vs-Asian |
2.010400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.883200E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.91479999966937E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.635600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.996100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.015200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.043900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.900600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.939600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.56539999995875E-06 |
| Classical-VS-Follicular |
2.056400E-01 |
| Classical-VS-Other |
9.206400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.935360E-03 |
| Tall-VS-Other |
1.797900E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
6.466600E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
1.155090E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.849000E-01 |
|
|
